CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	6 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)
Net loss	$ (16,196,318)	$ (18,606,098)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,973,982	1,867,192
Non-cash lease expense	9,545	43,594
Share-based payments for services	285,722	402,270
Equity-based compensation	3,436,119	6,655,002
Common stock contributed to 401(k) plan	105,043	110,072
Gain on short-term investments	0	(615)
Loss on patent impairment	0	30,793
Gain on derivative instruments	0	(366,791)
Loss on Receivables	0	54,922
(Increase)/decrease in assets:
Prepaid expenses	180,222	2,552
Supplies used for R&D and manufacturing	170,434	1,288
Deposits	(2,354,723)	1,910,917
Increase/(decrease) in liabilities:
Accounts payable	102,841	46,033
Accrued expenses	111,515	89,149
Due to employees	37,798	222,112
Net cash used in operating activities	(12,137,820)	(7,537,608)
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from maturity of US treasury bills	0	6,152,000
Purchases of property and equipment	(165,032)	(550,861)
Expenditures for patent costs	0	(22,741)
Net cash (used in) provided by investing activities	(165,032)	5,578,398
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments of stock issuance costs	(9,010)	(45,965)
Proceeds from exercises of warrants	447,291	101,225
Proceeds from the exercises of options	0	29,835
Proceeds from landlord funding of lease improvements	0	786,454
Payments on obligations under finance leases	(761,223)	(689,615)
Net cash (used in) provided by financing activities	(322,942)	181,934
NET DECREASE IN CASH AND CASH EQUIVALENTS	(12,625,794)	(1,777,276)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	22,672,138	36,060,148
CASH AND CASH EQUIVALENTS, END OF PERIOD		34,282,872
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Property and equipment purchases included in current liabilities	176,743	32,549
Finance lease obligation included in accounts payable	1,402	374
Prepaid consulting services paid with issuance of common stock	192,258	354,853
Exercise of derivative liabilities	0	70,589
Modification of finance leases	0	16,268
Financing costs included in current liabilities	0	4,550
Accrued consulting services to be paid with common stock	165,000	165,000
Cash paid for interest	$ 547,765	$ 578,837